FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

371766001: Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197063010 Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1207331011 Polymyxin B sulphate+bacitracin zinc 10,000u/500u ophthalmic ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1208143017 Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3730521000005110 polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve da Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve Is a polymyxin B-sulfat + bacitracinzink øjensalve false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B (substance) false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B sulfate false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antiinfektiøst middel til huden false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc bacitracin false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start